Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
Whats New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Zeposia (ozanimod)
pCPA File Number:
21521
Negotiation Status:
Negotiations were not pursued
Indication(s):
Relapsing-Remitting Multiple Sclerosis
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0652-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
2021-07-29